Evaluating Efficacy of Vedolizumab, Ustekinumab, and Golimumab in the Management of Inflammatory Bowel Disease and the Combined Role of Nutritional Therapy with Biologics: A Review

• Main Authors: Kamal, Shahed, Varshney, Karan, Uayan, Danielle Josefa F., Caliwag, Fides Myles C.
• Format: text
• Published: Archīum Ateneo 2024
• Subjects: biologic therapy; biologics; Crohn’s disease; inflammatory bowel disease; monoclonal antibodies; ulcerative colitis; Chemicals and Drugs; Gastroenterology; Medical Specialties; Medicine and Health Sciences
• Online Access: https://archium.ateneo.edu/asmph-pubs/279; https://archium.ateneo.edu/context/asmph-pubs/article/1283/viewcontent/biologics_04_00018.pdf
• Institution: Ateneo De Manila University

Inflammatory bowel disease (IBD), which encompasses both ulcerative colitis (UC) and Crohn’s disease (CD), is a major health burden worldwide. There are increasing concerns surrounding the impacts of this disease due to significant rises in the prevalence rates of IBD across the world. In considerat...